Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
May 1, 2018, 00:00
10.1016/j.jval.2018.04.298
https://www.valueinhealthjournal.com/article/S1098-3015(18)30598-9/fulltext
Title :
Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30598-9&doi=10.1016/j.jval.2018.04.298
First page :
Section Title :
Open access? :
No
Section Order :
1069